Goal:
Third-party payers in all countries are seeking better value for
money spent on treatments, drugs and devices, and are therefore
major users or consumers of outcomes and health economics studies.
It is increasingly important that health economics and outcomes
studies consider third-party payer evidence requirements and that
payers be educated on design and evidence and how information can
be properly used.
It is the goal of this ISPOR Special Interest Group to contribute
to international health technology assessment and reimbursement
research standards and methods, and create a forum for
communication between researchers, payers and the scientific and
academic communities at large.
|
